Abstract
Method for the synthesis of polymeric nanoparticles (NP) with encapsulated daunorubicin (DNR) was developed on the basis of double emulsion solvent evaporation technique using biodegradable poly(lactide-co-glycolide) (PLGA), which is aimed at customization of pharmacokinetic properties of the preparation, enhanced accumulation of DNR in tumor cells and prolongation of its action. The obtained polymer nanoparticles (DNR-PLGA) had average size ranging around 138±36 nm, with zeta-potential of –25.3 mV and the polydispersity index (PDI) of 0.072. The release kinetics of DNR from polymer nanoparticles at pH 7.4 and 5.0 has been studied. In vitro studies showed similar specific activity of DNR- PLGA in K562 and MCF-7 cancer cell lines together with an increase in activity in K562 Adr and MCF-7 Adr cell lines, which are anthracycline resistant, by 1.6 and 3.4 times. The study demonstrated the efficacy of the developed PLGA-based DNR delivery system in the improvement of antitumor effect of DNR, overcoming multidrug resistance in cancer cells, and also in the decrease in nonspecific toxicity of the preparation.
Similar content being viewed by others
References
M. B. Bychkov, E. K. Vosniy, A. M. Garin, V. A. Gorbunova, N. F. Orel, N. I. Perevodchikova, M. N. Preobrazhenskaya, M. B. Stenina, S. A. Tulyandin, Novye tsitostatiki v lechenii zlokachestvennykh opukholei [New Cytostatics in the Treatment of Malignant Tumors], RONTs im. N. N. Blokhina, Moscow, 1998, 128 pp. (in Russian).
O. Yu. Baranova, M. A. Volkova, Russ. Medical J. (Int. Ed.), 2001, 22 [Rus. Med. Zhurn., 2001, 22, 199] (in Russian).
A. V. Pivnik, Russ. Medical J. (Int. Ed.), 1999, 10 [Rus. Med. Zhurn., 1999, 10, 5] (in Russian).
A. L. A. Ferreira, L. S. Matsubara, B. B. Matsubara, Cardiovascular and Hematological Agents in Medicinal Chemistry, 2008, 4,278.
I. V. Poddubnaya, Russ. Medical J. (Int. Ed.), 1998, 10 [Rus. Med. Zhurn., 1998, 10, 2] (in Russian).
E. S. Severin, A. V. Rodina, Uspekhi biol. Khimii, 2006, 46, 43 (in Russian).
P. Ma, R. J. Mumper, Nano Today, 2013, 8,313.
J.-P. Gillet, T. Efferth, J. Remacle, Biochimica et Biophysica Acta (BBA)–Reviews on Cancer, 2007, 2,237.
E. S. Severin, Russ. Chem. Rev., 2015, 84,43.
D. Krajišnik, B. Čalija, N. Cekic, Formulation Challenges and Potential Benefits, 2017, 2,31.
K. V. Alekseev, I. N. Gritskova, S. A. Kedic, Polimery dlia farmatsevticheskoi tekhnologii [Polymers for Pharmaceutical Technology], SARMA, Moscow 2011, 511 pp. (in Russian).
R. Jalil, J. R. Nixon, J. Microencapsulation, 1990, 7,297.
P. A. Gunatillake, R. Adhikari, Europuan Cells & Matherials, 2003, 5,1.
CN Pat. 1973843.
J. Liu, Z. Qiu, S. Wang, L. Zhou, S. Zhang, Biomedical Materials, 2010, 5,1.
B. Han, B. Shen, Z. Wang, Polym. Adv. Technol., 2008, 9,36.
P. P. G. Guimarães, M. F. Oloveira, A. D. M. Gomes, S. M. L. Gontijo, M. E. Cortés, P. P. Campos, C. T. R. Viana, S. P. Andrade, R D. Sinisterra, Colloids and Surfaces B: Biointerfaces, 2015, 136,248.
K. Nan, F. Ma, H. Hou, W. R. Freeman, M. J. Sailor, L. Cheng, Acta Biomaterialia, 2014, 10, 3505.
N. V. Gukasova, O. A. Zhunina, E. D. Nikolskaya, A. V. Pomazkov, M. A. Sapelkin, E. S. Severin, O. G. Tereshchenko, N. G. Yabbarov, FIPS application № 2016118302/15(028761) from 21.03.2017 (in Russian).
Y. Zhang, M. Huo, J. Zhou, A. Zou, W. Li, C. Yao, S. Xie, The AAPS J., 2010, 12,263.
T. Mosmann, J. Immunol. Meth., 1983, 65,55.
E. M. Treshchalina, O. S. Zukova, G. K. Gerasimova, N. V. Andronova, A. M. Garin, Metodicheskie ukazaniya po izuche niyu protivoopukholevoi aktivnosti farmakologicheskikh veshchestv. Rukovodstvo po eksperimental`nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Guidelines for Examination of Antitumor Activity of Medicinal Compounds. Guidelines for Conduction of Preclinical Trial of New Medicinal Compounds], Medicina, 2005, 832 pp. (in Russian).
N. A. Peppas, Pharm. Acta Helv., 1985, 60,110.
M. Rahimi, H. Mobedi, A. Behnamghader, J. Micro encapsulation, 2016, 33,355.
T. G. Soni, J. U. Desai, C. D. Nagda, T. R. Gandhi, N. P. Chotai, Die Pharmazie Intern. J. Pharmaceutical Sci., 2008, 63, 31–34.
Y. Urasaki, T. Ueda, A. Yoshida, T. Fukushima, Anticancer Res., 1996, 16, 709.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 4, pp. 0747–0756, April, 2018.
Rights and permissions
About this article
Cite this article
Nikolskaya, E.D., Faustova, M.R., Mollaev, M.D. et al. Development of a polymer system for the delivery of daunorubicin to tumor cells to overcome drug resistance. Russ Chem Bull 67, 747–756 (2018). https://doi.org/10.1007/s11172-018-2132-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-018-2132-5